IP Library Granted Patent US 11,191,956
Granted Patent B2
US 11,191,956 · App. 17/038,950 · Granted Dec 7, 2021

Reducing motility of cancer cells using tumor treating fields (TTFields)

Inventors: Moshe Giladi (Moshav Herut, IL); Rosa S. Shnaiderman (Haifa, IL)
Assignee: Novocure GmbH
A61N1/32A61N1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,191,956
App. No.
17/038,950
Granted
Dec 7, 2021
Kind
B2
Abstract

The spreading of cancer cells in a target region can be inhibited by imposing a first AC electric field in the target region for a first interval of time, with a frequency and amplitude selected to disrupt mitosis of the cancer cells; and imposing a second AC electric field in the target region for a second interval of time, with a frequency and the amplitude selected to reduce motility of the cancer cells. The amplitude of the second AC electric field is lower than the amplitude of the first AC electric field.

Claims (4)

1. A method of inhibiting spreading of cancer cells in a target region, the method comprising:

(a) imposing a first AC electric field in the target region, the first AC electric field having a first frequency and a first amplitude, wherein the first frequency and the first amplitude are selected so that the first AC electric field disrupts mitosis of the cancer cells; and

(b) imposing a second AC electric field in the target region, the second AC electric field having a second frequency and a second amplitude, wherein the second frequency and the second amplitude are selected so that the second AC electric field reduces motility of the cancer cells, wherein the second frequency and the first frequency are different, and wherein the second amplitude is lower than the first amplitude.

2. The method of claim 1 , wherein the second amplitude is less than 75% of the first amplitude.

Assignments (3)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: GILADI, MOSHE; SHNAIDERMAN, ROSA
To: NOVOCURE LIMITED
Reel/Frame 053935/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 053936/0021 →
Cited By (17)
US 12,357,821 US 12,377,280 US 12,397,151 US 12,403,306 US 12,440,680 US 12,478,793 US 12,502,548 US 12,508,437 US 12,551,698 US 12,558,538 US 12,599,765 US 12,629,511 US 12,649,056 US 12,649,061 US 12,661,507 US 12,673,212 US 12,678,620